Table 1.
Baseline Demographics and Clinical Characteristics, Enrolled Safety Population
| MPH ERCT (n = 90) | |
|---|---|
| Gender, n (%) | |
| Male | 55 (61.1) |
| Female | 35 (38.9) |
| Mean ± SD age, years | 9.5 (1.73) |
| Age categories, (%) | |
| 6–7 years | 16 (17.8) |
| 8–10 years | 47 (52.2) |
| 11–12 years | 27 (30.0) |
| Race, n (%) | |
| White | 52 (57.8) |
| Black/African American | 32 (35.6) |
| Asian | 1 (1.1) |
| Other | 5 (5.6) |
| Ethnicity, n (%) | |
| Hispanic/Latino | 13 (14.4) |
| Non-Hispanic/Latino | 77 (85.6) |
| ADHD type, n (%) | |
| Inattentive | 23 (25.6) |
| Hyperactive/impulsive | 0 |
| Combined | 67 (74.4) |
ADHD, attention-deficit/hyperactivity disorder; ADHD-RS-IV, attention-deficit/hyperactivity disorder rating scale; MPH ERCT, methylphenidate extended-release chewable tablets; SD, standard deviation.